Solventum Corporation (BMV:SOLV)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States Revenue	4.73B	4.75B	4.60B
United States Revenue Growth	-0.40%	3.17%	3.44%
International Revenue	3.67B	3.51B	3.59B
International Revenue Growth	4.76%	-2.48%	-2.34%
Revenue (Total)	8.40B	8.25B	8.20B
Revenue (Total) Growth	1.79%	0.69%	0.82%

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
MedSurg Revenue	4.76B	4.64B	4.63B
MedSurg Revenue Growth	2.54%	0.11%	1.03%
Dental Solutions Revenue	1.32B	1.30B	1.33B
Dental Solutions Revenue Growth	2.01%	-2.56%	0.15%
Health Information Systems Revenue	1.35B	1.31B	1.29B
Health Information Systems Revenue Growth	3.29%	1.63%	4.73%
Purification and Filtration Revenue	857.00M	956.00M	951.00M
Purification and Filtration Revenue Growth	-10.36%	0.53%	-4.04%
Corporate and Unallocated Revenue	119.00M	59.00M	-
Corporate and Unallocated Revenue Growth	101.70%	-	-
Revenue (Other)	1.00M	1.00M	-
Revenue (Total)	8.40B	8.25B	8.20B
Revenue (Total) Growth	1.79%	0.69%	0.82%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Product Revenue	6.44B	6.35B	6.30B
Product Revenue Growth	1.45%	0.83%	-0.06%
Software and Rental Revenue	1.96B	1.91B	1.90B
Software and Rental Revenue Growth	2.89%	0.26%	3.88%
Revenue (Total)	8.40B	8.25B	8.20B
Revenue (Total) Growth	1.79%	0.69%	0.82%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
MedSurg Operating Income	827.00M	887.00M	1.11B
MedSurg Operating Income Growth	-6.76%	-19.87%	4.34%
Dental Solutions Operating Income	334.00M	350.00M	442.00M
Dental Solutions Operating Income Growth	-4.57%	-20.81%	1.14%
Health Information Systems Operating Income	477.00M	431.00M	423.00M
Health Information Systems Operating Income Growth	10.67%	1.89%	17.83%
Purification and Filtration Operating Income	125.00M	94.00M	162.00M
Purification and Filtration Operating Income Growth	32.98%	-41.98%	-8.48%
Corporate Operating Income	429.00M	-726.00M	-442.00M
Operating Income (Total)	2.19B	1.04B	1.69B
Operating Income (Total) Growth	111.58%	-38.77%	-0.06%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Organic Sales Growth	1.20%	1.40%

Updated Sep 30, 2025. Data Source: Fiscal.ai.